Pinheiro, Elaine M.
Merck & Co., Inc., Rahway, NJ, USA (United States)
3 papers on CoChat
Most cited papers
- Verified
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors.
Morris, E. J., Jha, S., Restaino, C. R., Dayananth, P., Zhu, H., Cooper, A., Carr, D., Deng, Y., Jin, W., Black, S., et al. (2013) · Cancer Discovery
Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 676
- Verified
Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression
Hossain, D. M. S., Javaid, S., Cai, M., Zhang, C., Sawant, A., Hinton, M., Sathe, M., Grein, J., Blumenschein, W., Pinheiro, E. M., et al. (2018) · Journal of Clinical Investigation
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 216
- Verified
Nervous Rac: DOCK7 Regulation of Axon Formation
Pinheiro, E. M., & Gertler, F. B. (2006) · Neuron
Axon Guidance and Neuronal SignalingNeurogenesis and neuroplasticity mechanisms
Cited by 12
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free